肝纤维化评价指标对心力衰竭预后价值的研究进展
作者:
作者单位:

(山西医科大学第三医院·山西白求恩医院·山西医学科学院·同济山西医院心血管内科,太原 030032)

作者简介:

通讯作者:

中图分类号:

R541.6

基金项目:

山西省回国留学人员科研资助项目(2020-179)


Research progress on prognostic value of evaluation indexes of hepatic fibrosis for heart failure
Author:
Affiliation:

(Department of Cardiology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    由于患病率及病死率居高不下,心力衰竭一直是影响我国国民健康的重大医疗问题,心力衰竭常会引起其他器官功能障碍,增加诊疗难度,如果合并其他器官功能障碍,则患者预后较单纯心力衰竭更差。心力衰竭时,心输出量下降及静脉淤血可导致肝脏出现心源性纤维化,研究显示合并肝纤维化的心力衰竭患者死亡率更高,提示合并肝纤维化的心力衰竭患者预后不良。有学者认为肝纤维化与心力衰竭的预后有关,部分肝纤维化评价指标在心力衰竭预后评价中显示出了良好的临床价值,本文对肝纤维化指标进行综述。

    Abstract:

    Due to the high prevalence and fatality rate, heart failure has always been a major medical problem affecting the health of Chinese people. Heart failure often causes dysfunction of other organs, increasing the difficulty of diagnosis and treatment. Complicated with dysfunction of other organs, the prognosis of patients is worse than that of those with simple heart failure. In heart failure, decreased cardiac output and venous congestion lead to cardiac hepatic fibrosis. Studies have shown that heart failure patients with hepatic fibrosis have a higher mortality rate, suggesting a poor prognosis in them. Some scholars claim that liver fibrosis is related to the prognosis of heart failure and that some indexes of hepatic fibrosis have shown prognostic value for heart failure. This article reviews the indexes of hepatic fibrosis.

    参考文献
    相似文献
    引证文献
引用本文

王笛琨,张丽晖,国志尊,丁鹏飞,陈剑楠,张皓楠,谭欣毓,郭园园.肝纤维化评价指标对心力衰竭预后价值的研究进展[J].中华老年多器官疾病杂志,2024,23(5):386~389

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-07-05
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-05-15
  • 出版日期: